id:"swepub:oai:DiVA.org:uu-371061"
Sökning: id:"swepub:oai:DiVA.org:uu-371061" > Co-localisation of ...
- 1 av 1
- Föregående post
- Nästa post
- Till träfflistan
- Koyi, HirshKarolinska Institutet,Uppsala universitet,Centrum för klinisk forskning, Gävleborg,Gavle Cent Hosp, Dept Resp Med, S-80187 Gavle, Sweden;Karolinska Inst, Stockholm, Sweden (författare)
Co-localisation of Glandular and Squamous Cell Markers in Non-small Cell Lung Cancer
- Artikel/kapitelEngelska2018
Förlag, utgivningsår, omfång ...
- 2018-05-30
- Anticancer Research USA Inc.2018
- printrdacarrier
Nummerbeteckningar
- LIBRIS-ID:oai:DiVA.org:uu-371061
- https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-371061URI
- https://doi.org/10.21873/anticanres.12600DOI
- http://kipublications.ki.se/Default.aspx?queryparsed=id:139540981URI
Kompletterande språkuppgifter
- Språk:engelska
- Sammanfattning på:engelska
Ingår i deldatabas
- SwePubSwePub
Klassifikation
Anmärkningar
- Aim: Accurate classification of lung carcinomas is crucial for selecting appropriate and adequate chemotherapy treatment. In this study, glandular (adenocarcinoma), and squamous cell differentiation were examined in non-small cell lung carcinoma (NSCLC) without obvious light-microscopic signs of squamous and glandular differentiation. Materials and Methods: All lung tumours diagnosed as NSCLC (n=61), without obvious squamous or glandular features, were obtained by bronchial biopsy or core biopsy supported by computed tomography. They were diagnosed during 1996-2009, at the Department of Pathology, Gavle Hospital, Sweden. The tumours were examined immunohistochemically with antibodies against CK5/6, p63 (squamous cell markers) and carcinoembryonic antigen (CEA) (adenocarcinoma cell marker). Double immunostaining (p63/CEA) was also performed on individual tumours. Results: The tumours originated from 36 males and 25 females, aged 54-83 years. Pure squamous cell differentiation (CK5/6 positive only) occurred in 34.4% (n=21) tumours and pure adenocarcinoma cell differentiation (CEA positive only) was present in 14.9% (n=9). Tumours with both squamous and adenocarcinoma features (CK5/6 and CEA positive) were most prevalent (47.5%, n=29). Two tumours (3.3%) were negative with both stains (and also synaptophysin negative). Double immunostaining (p63/CEA) revealed that squamous and adenocarcinoma markers were co-localised in cells in certain tumours. Conclusion: Co-localisation of squamous and adenocarcinoma markers in the same tumour cell suggests that additional analyses for novel biomarkers of specific lung cancer types may subsequently lead to a refined treatment choice for patients with the goal of improving clinical outcomes.
Ämnesord och genrebeteckningar
- MEDICIN OCH HÄLSOVETENSKAP Klinisk medicin Cancer och onkologi hsv//swe
- MEDICAL AND HEALTH SCIENCES Clinical Medicine Cancer and Oncology hsv//eng
- Lung cancer
- squamous cell carcinoma
- adenocarcinoma
- CEA
- CK5/6 expression
Biuppslag (personer, institutioner, konferenser, titlar ...)
- Brandén, EvaUppsala universitet,Centrum för klinisk forskning, Gävleborg,Gavle Cent Hosp, Dept Resp Med, S-80187 Gavle, Sweden;Karolinska Inst, Stockholm, Sweden(Swepub:uu)evabr789 (författare)
- Kasim, IhsanGavle Cty Hosp, Dept Pathol, Gavle, Sweden (författare)
- Wilander, ErikGavle Cty Hosp, Dept Pathol, Gavle, Sweden (författare)
- Uppsala universitetCentrum för klinisk forskning, Gävleborg (creator_code:org_t)
Sammanhörande titlar
- Ingår i:Anticancer Research: Anticancer Research USA Inc.38:6, s. 3341-33460250-70051791-7530
Internetlänk
- 1 av 1
- Föregående post
- Nästa post
- Till träfflistan
Hitta mer i SwePub
- Av författaren/redakt...
- Koyi, Hirsh
- Brandén, Eva
- Kasim, Ihsan
- Wilander, Erik
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
- MEDICIN OCH HÄLS ...
- och Klinisk medicin
- och Cancer och onkol ...
- Artiklar i publikationen
- Anticancer Resea ...
- Av lärosätet
- Uppsala universitet
- Karolinska Institutet
Sök utanför SwePub
- Sök vidare i:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - Nationella bibliotekssystem
- LIBRIS.kb.se
